Evidence used
- No CISA KEV confirmation is currently recorded.
- A structured source references public exploit or proof-of-concept material.
- EPSS is 0.16% for the current model date.
BlackTreeCVE IntelligenceFull vulnerability report · 2026
CVE-2026-105706High confidence
SourceCodester Drug Recommendation System cross-site request forgery
SourceCodester · Drug Recommendation System
5.3MediumCVSS 4.0
Within 7 days
Fix not verifiedMedium technical severity with public exploit material referenced by a structured source; prioritise exposed affected systems while verifying vendor guidance.
R
Open reassessment dashboard →Operational reassessment
Published severity in operational context
Published severityMedium→Operational priority:High, raised one band.upgradedsince 6 Oct 2026
Compensating controls
- Restrict the affected network interface to trusted sources where business-safe.
- Increase monitoring for the attack path and post-exploitation behaviour described in the report.
Verification
- Confirm that the asset runs SourceCodester Drug Recommendation System and falls inside the recorded affected range.
- Recheck the vendor advisory before scheduling a change because no verified fixed version is currently retained.
- Validate exposure, authentication requirements and compensating controls in the actual environment.
- Reopen this reassessment when CVSS, KEV, EPSS, exploit evidence or remediation changes.
Medium technical severity with public exploit material referenced by a structured source; prioritise exposed affected systems while verifying vendor guidance.
Fix not verified01
What, why and how
A weakness has been identified in SourceCodester Drug Recommendation System 1.0. Affected is an unknown function. Executing a manipulation can lead to cross-site request forgery. The attack may be performed from remote. The exploit has been made available to the public and could be used for attacks.
What
A weakness has been identified in SourceCodester Drug Recommendation System 1.0. Affected is an unknown function. Executing a manipulation can lead to cross-site request forgery. The attack may be performed from remote. The exploit has been made available to the public and could be used for attacks.
Why
The application accepts a state-changing browser request without a reliable anti-forgery check.
How
An attacker operating through a network path may attempt exploitation when the stated preconditions are met. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
What
A weakness has been identified in SourceCodester Drug Recommendation System 1.0. Affected is an unknown function. Executing a manipulation can lead to cross-site request forgery. The attack may be performed from remote. The exploit has been made available to the public and could be used for attacks.
Why
The application accepts a state-changing browser request without a reliable anti-forgery check.
How
An attacker operating through a network path may attempt exploitation when the stated preconditions are met. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
02
Exploit reality and attack path
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
Observed exploitation No confirmed evidence
?
Confirmed exploitation and public exploit material are separate signals. Attacks can occur without public proof-of-concept or exploit code.No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
Public PoC / exploit material Reference recorded
?
Confirmed exploitation and public exploit material are separate signals. Attacks can occur without public proof-of-concept or exploit code.CISA Vulnrichment records proof-of-concept exploitation in its SSVC data. BlackTree has not independently executed or validated exploit material.
- Likely attack path
- a network path → Cross-Site Request Forgery (CSRF) → cause the confidentiality, integrity or availability impact described by the vendor
- Attack surface
- Network
- Privileges required
- None: unauthenticated exploitation is possible
- User interaction
- Passive interaction required
- Attack complexity
- Low: no specialised conditions are recorded
- Security boundary
- Not a CVSS 4.0 base metric
- Weakness
?
CWE means Common Weakness Enumeration: a standard category for the underlying weakness. - CWE-352 ↗
CWE-352: Cross-Site Request Forgery (CSRF). The web application does not, or cannot, sufficiently verify whether a request was intentionally provided by the user who sent the request, which could have originated from an unauthorized actor.
- CVSS vector
?
CVSS means Common Vulnerability Scoring System. The vector records the metric values used to calculate technical severity. CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:PCommon Vulnerability Scoring System 4.0: the compact vector below is decoded into plain language.
AVNetworkAttack vector: The vulnerable component can be reached over a network.ACLowAttack complexity: No specialised conditions are required beyond attacker-controlled input.ATNoneAttack requirements: No additional deployment or execution condition is required.PRNonePrivileges required: The attacker does not need an account or existing privileges.UIPassiveUser interaction: A user must unknowingly interact with the vulnerable system.VCNoneVulnerable-system confidentiality: No direct loss is represented by this metric.VILowVulnerable-system integrity: A successful attack can cause a limited loss.VANoneVulnerable-system availability: No direct loss is represented by this metric.SCNoneSubsequent-system confidentiality: No direct loss is represented by this metric.SINoneSubsequent-system integrity: No direct loss is represented by this metric.SANoneSubsequent-system availability: No direct loss is represented by this metric.- Post-exploitation / living off the land
- No specific living-off-the-land technique is confirmed in the structured sources. Monitor normal administration tools for activity inconsistent with the affected service's baseline.
03
Patch and workaround
Operational remediation based on structured source evidence.
- Status
?
Patch availability is based on structured fixed-version fields and authoritative update references. If no fix is verified, check the vendor advisory before making a change. - Fix not verified
- Affected
- Drug Recommendation System: 1.0
- Fixed
- No fixed version is explicitly recorded in the structured CVE data.
- Action
- No verified patch reference is present in the current structured sources. Check the vendor advisory before making a change.
- Workaround
- No verified workaround is recorded. If business-safe, reduce exposure to the affected interface and allow only trusted sources until authoritative guidance is available.
04
Evidence and provenance
Published 6 Oct 2026 · Last source change 6 Oct 2026, 13:09 UTC · CWE-352 · Cross-Site Request Forgery (CSRF)
CVE recordCVE.org · 5.2
CVSS sourceCNA
EPSS source FIRST · tracked since 2026-10-06
?
The date BlackTree first stored a score for this CVE from the daily FIRST EPSS feed.European sourceENISA EUVD · EUVD-2026-92947
Product sourceCNA
Remediation sourceCVE/CNA references
CWE sourceCNA
NVD statusNVD not scheduled
Core structured fields are present and their contributing authorities are shown above.
Material change intelligence
View recent updates ↗What changed after publication
- ENISA EUVD mappingEUVD-2026-92947 was added to the official ENISA EUVD mapping for this CVE.ENISA EUVD ↗
- Before
- not recorded
- After
- {"euvdId":"EUVD-2026-92947"}
- Public exploit evidencePublic exploit evidence changed from No public exploit to Public exploit reference.CVE.org ↗
- Before
- No public exploit
- After
- Public exploit reference
- Catalogue recordCVE added to the BlackTree catalogue.CNA ↗
- SeveritySeverity changed from Low to Medium.CNA ↗
- Before
- Low
- After
- Medium
- CVSS scoreCVSS score changed from 2.1 (CVSS 4.0 · CNA · CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X) to 5.3 (CVSS 4.0 · CNA · CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P).CNA ↗
- Before
- 2.1 (CVSS 4.0 · CNA · CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X)
- After
- 5.3 (CVSS 4.0 · CNA · CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P)
Technical terms and abbreviations used in this report
- CVE
- Common Vulnerabilities and Exposures: the public identifier for one disclosed vulnerability.
- CVSS
- Common Vulnerability Scoring System: a technical severity framework; it is not patching priority by itself.
- EPSS
- Exploit Prediction Scoring System: FIRST's estimate of the probability that exploitation activity will be observed in the next 30 days; it is a forecast, not confirmation.
- CWE
- Common Weakness Enumeration: the standard category describing the underlying software or hardware weakness.
- CNA
- CVE Numbering Authority: an organisation authorised to assign and publish CVE records.
- CISA ADP
- Cybersecurity and Infrastructure Security Agency Authorized Data Publisher: structured enrichment added to a CVE record.
- NVD
- National Vulnerability Database: NIST's enrichment service for CVE records.
- CERT / CSIRT
- A computer security incident response team that publishes warnings or coordinates incident response.
- PoC
- Proof of concept: public material that demonstrates or helps reproduce exploitation.
- CSAF
- Common Security Advisory Framework: a machine-readable format for security advisories.
- LoTL
- Living off the land: abuse of legitimate tools or system functions during an attack.